These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1769006)

  • 1. New nitrosoureas and their spin-labeled derivatives influence dopa-oxidase activity of tyrosinase.
    Rachkova M; Raikova E; Raikov Z
    Cancer Biochem Biophys; 1991 Jun; 12(1):59-64. PubMed ID: 1769006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating effect of new potential antimelanomic agents, spin-labeled triazenes and nitrosoureas on the DOPA-oxidase activity of tyrosinase.
    Gadjeva V; Zheleva A; Raikova E
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):99-108. PubMed ID: 10738906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents.
    Gadjeva V
    Eur J Med Chem; 2002 Apr; 37(4):295-300. PubMed ID: 11960664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spin labeled amino acid nitrosourea derivatives--synthesis and antitumour activity.
    Zheleva A; Raikov Z; Ilarionova M; Todorov D
    Pharmazie; 1995 Jan; 50(1):25-6. PubMed ID: 7886121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spin labelled nitrosoureas and triazenes and their non-labelled clinically used analogues--a comparative study on their physicochemical properties and antimelanomic effects.
    Zheleva AM; Gadjeva VG
    Int J Pharm; 2001 Jan; 212(2):257-66. PubMed ID: 11165083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase.
    Shin NH; Ryu SY; Choi EJ; Kang SH; Chang IM; Min KR; Kim Y
    Biochem Biophys Res Commun; 1998 Feb; 243(3):801-3. PubMed ID: 9500997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Oguro M; Yanagawa T; Takenaga K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and study of spin-labeled nitrosoureas.
    Raikov Z; Todorov D; Ilarionova M; Demirov G; Tsanova T; Kafalieva D
    Cancer Biochem Biophys; 1985 Feb; 7(4):343-8. PubMed ID: 2983881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
    Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of polyamines on tyrosinase activity.
    Galindo JD; Martinez JH; Lopez-Ballester JA; Peñafiel R; Solano F; Lozano JA
    Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In the search for new anticancer drugs XII. Synthesis and biological evaluation of spin labeled nitrosoureas.
    Sosnovsky G; Li SW
    Life Sci; 1985 Apr; 36(15):1479-83. PubMed ID: 3982222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties.
    Zheleva A; Stanilova S; Dobreva Z; Zhelev Z
    Int J Pharm; 2001 Jul; 222(2):237-42. PubMed ID: 11427354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mushroom tyrosinase has an ascorbate oxidase activity.
    Ros JR; Rodríguez-López JN; Varón-Castellanos R; García-Canovas F
    Biochem Mol Biol Int; 1995 Jun; 36(2):301-9. PubMed ID: 7663434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.
    Cho SJ; Roh JS; Sun WS; Kim SH; Park KD
    Bioorg Med Chem Lett; 2006 May; 16(10):2682-4. PubMed ID: 16513349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma.
    Kern DH; Shoemaker RH; Hildebrand-Zanki SU; Driscoll JS
    Cancer Res; 1988 Sep; 48(18):5178-82. PubMed ID: 3136917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of substituted DL-3(5-benzazolyl)alanines as dopa and alpha-methyldopa analogs and their effects on dopamine beta-hydroxylase, tyrosinase and diphenoloxidase.
    Loriga M; Paglietti G; Sparatore F; Pinna G; Sisini A
    Farmaco; 1992 Apr; 47(4):439-48. PubMed ID: 1388592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
    Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of spin-labelled nitrosourea on CCNU-induced oxidative stress in rat blood compared with vitamin E.
    Gadjeva V; Kuchukova D; Tolekova A; Tanchev S
    Pharmazie; 2005 Jul; 60(7):530-2. PubMed ID: 16076081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.